DE69505236D1 - Liposomen und deren verwendung insbesondere zur herstellung immunomodulatorischer mittel - Google Patents

Liposomen und deren verwendung insbesondere zur herstellung immunomodulatorischer mittel

Info

Publication number
DE69505236D1
DE69505236D1 DE69505236T DE69505236T DE69505236D1 DE 69505236 D1 DE69505236 D1 DE 69505236D1 DE 69505236 T DE69505236 T DE 69505236T DE 69505236 T DE69505236 T DE 69505236T DE 69505236 D1 DE69505236 D1 DE 69505236D1
Authority
DE
Germany
Prior art keywords
liposomes
production
immunomodulative
agents
phospholipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69505236T
Other languages
English (en)
Other versions
DE69505236T2 (de
Inventor
Gilles Riveau
Andre Capron
Nathalie Ivanoff
Jean-Marie Grzych
Nigel Phillips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of DE69505236D1 publication Critical patent/DE69505236D1/de
Publication of DE69505236T2 publication Critical patent/DE69505236T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69505236T 1994-02-23 1995-02-23 Liposomen und deren verwendung insbesondere zur herstellung immunomodulatorischer mittel Expired - Fee Related DE69505236T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9402070A FR2716373B1 (fr) 1994-02-23 1994-02-23 Liposomes, et leur utilisation pour l'obtention de vaccins.
PCT/FR1995/000215 WO1995022961A1 (fr) 1994-02-23 1995-02-23 Liposomes, et leur utilisation notamment pour l'obtention de compositions immunomodulatrices

Publications (2)

Publication Number Publication Date
DE69505236D1 true DE69505236D1 (de) 1998-11-12
DE69505236T2 DE69505236T2 (de) 1999-05-20

Family

ID=9460360

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69505236T Expired - Fee Related DE69505236T2 (de) 1994-02-23 1995-02-23 Liposomen und deren verwendung insbesondere zur herstellung immunomodulatorischer mittel

Country Status (5)

Country Link
EP (1) EP0748214B1 (de)
AT (1) ATE171867T1 (de)
DE (1) DE69505236T2 (de)
FR (1) FR2716373B1 (de)
WO (1) WO1995022961A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769022B1 (fr) * 1997-09-29 2000-11-03 Capsulis Vecteurs d'antigenes et compositions therapeutiques contenant des antigenes
FR2850872A1 (fr) * 2003-02-12 2004-08-13 Ethypharm Sa Composition vaccinale destinee a induire une reponse immunitaire contre le virus responsable du sida

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0440742B1 (de) * 1988-10-27 1997-01-15 The Regents Of The University Of Minnesota Immunhilfsmittel aus Liposome enthaltend Lymphokin IL -2
HUT67159A (en) * 1991-05-13 1995-02-28 Univ California Liposomal polysaccharide vaccines
DE69232395T2 (de) * 1991-11-26 2002-11-14 Jenner Technologies, Walworth Antitumorvakzine
PT100487B (pt) * 1992-05-14 1999-07-30 Univ Texas Formulacoes lipossomais de rifamicinas com elevada estabilidade e eficacia de incorporacao de antibiotico, e processo para a sua preparacao

Also Published As

Publication number Publication date
EP0748214B1 (de) 1998-10-07
EP0748214A1 (de) 1996-12-18
FR2716373A1 (fr) 1995-08-25
WO1995022961A1 (fr) 1995-08-31
DE69505236T2 (de) 1999-05-20
FR2716373B1 (fr) 1996-05-03
ATE171867T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
ATE288260T1 (de) Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, verfahren zur herstellung der formulierung sowie anwendung derselben
DE69531533D1 (de) Glaszusammensetzung zur herstellung von verglasungen
DE3864585D1 (de) Dns-molekule, codierend fuer non-a-non-b-hepatitis-antigene und ihre verwendung zur herstellung dieser antigene.
DE69822919D1 (de) Spezifische Antikörper zur Verwendung in der Herstellung pharmazeutischer Zusammensetzungen nützlich für die Vorbeugung oder Behandlung von Gastritis, Magen- und Zwölffingerdarmgeschwüren
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
ATE165970T1 (de) Bade- und duschzusätze mit vesikelbildenden eigenschaften, ihre herstellung und verwendung
DE69530592D1 (de) Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafür
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
DE60212425D1 (de) Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
DE69321687D1 (de) Durchlässige materialkomposition, durchlässiges material und dessen herstellung
DE69509007D1 (de) Konzentrierte Prepolymerzusammensetzung zur Herstellung von Polyimidformkörpern
DE58904434D1 (de) Organische derivate von rheniumoxiden sowie ihre herstellung und verwendung zur metathese von olefinen.
DE59611111D1 (de) Phospholipid-derivate von phosphonocarbonsäuren, deren herstellung sowie deren verwendung als antivirale arzneimittel
DE69822711D1 (de) Verfarhen zur Herstellung von Dialkylnaphthalinen
DE69505236D1 (de) Liposomen und deren verwendung insbesondere zur herstellung immunomodulatorischer mittel
DE60239670D1 (de) Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis
FI951759A0 (fi) Menetelmä 2,2-difluoriketeenisilyyli-O,S-asetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihapon O,S-estereiden valmistamiseksi
DE69903880D1 (de) Oxidationskatalysator-System und dessen Verwendung zur Herstellung von Ketoisophoron
DE69229969D1 (de) Methode zur bildung von liposomen und zusammensetzungen zur deren herstellung
DE69333302D1 (de) Mikroorganismen, ihre herstellung und verwendung
DE3484355D1 (de) Gefaerbte wasserfreie mittel fuer kosmetische, medizinische und aehnliche zwecke, sowie deren herstellung.
DE3582371D1 (de) Oxindolverbindungen, diese enthaltende zusammensetzungen sowie verfahren zur herstellung derselben.
ATE261438T1 (de) Produkte für körperhygiene basierend auf lapacho extrakte enthaltend quercetin, deren herstellung und verwendung
DE69842119D1 (de) Methode zur herstellung von canine interleukin 18

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee